Article
Blood Test Results May Offer Clues to Neurotoxicity Risk After CAR-T Cell Therapy in Cancer
Rating:
0.0
Views:
72
Likes:
1
Library:
1
Patients with blood cancer who have higher levels of neurofilament light chains — which indicate brain injury — were found to be more likely to develop neurotoxicity after CAR-T cell therapy, according to recent research.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value